Goldman Sachs’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,112,183
Closed -$66M 7519
2014
Q4
$66M Sell
1,112,183
-2,601,219
-70% -$149M 0.02% 910
2014
Q3
$168M Sell
3,713,402
-925,968
-20% -$41.7M 0.05% 404
2014
Q2
$206M Sell
4,639,370
-2,082,825
-31% -$86.2M 0.06% 351
2014
Q1
$270M Sell
6,722,195
-1,090,278
-14% -$44.1M 0.09% 236
2013
Q4
$311M Buy
7,812,473
+229,626
+3% +$8.93M 0.1% 203
2013
Q3
$280M Buy
7,582,847
+4,307,260
+131% +$161M 0.1% 192
2013
Q2
$121M Buy
+3,275,587
New +$116M 0.05% 463

Other funds holding CFN

Goldman Sachs's CFN Position: Q1 2015 in Review

Goldman Sachs sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 1,112,183 shares — an estimated $66M sold.

Goldman Sachs first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $311M in Q4 2013. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • Goldman Sachs reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 1,112,183 CAREFUSION CORPORATION shares in Q1 2015, an estimated $66M.
  • Goldman Sachs first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • Goldman Sachs's CAREFUSION CORPORATION position peaked at $311M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.